Detalhe da pesquisa
1.
Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer: Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212).
Int J Cancer
; 154(5): 863-872, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37840339
2.
TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer.
Br J Cancer
; 129(1): 175-182, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142730
3.
Standard diametric versus volumetric early tumor shrinkage as a predictor of survival in metastatic colorectal cancer: subgroup findings of the randomized, open-label phase III trial FIRE-3 / AIO KRK-0306.
Eur Radiol
; 33(2): 1174-1184, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35976398
4.
Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial.
Lancet Oncol
; 23(1): 115-124, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34919824
5.
The impact of adjuvant therapy on outcome in UICC stage I pancreatic cancer.
Int J Cancer
; 151(6): 914-919, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35467760
6.
Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306).
Int J Cancer
; 150(1): 112-123, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34431518
7.
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3).
Int J Cancer
; 150(8): 1341-1349, 2022 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34807464
8.
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3.
Br J Cancer
; 127(5): 836-843, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35637412
9.
FIRE-9 - PORT / AIO-KRK-0418: a prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of adjuvant/additive chemotherapy in patients with definitely-treated metastatic colorectal cancer.
BMC Cancer
; 22(1): 359, 2022 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35366831
10.
Distress in hospitalized cancer patients: Associations with personality traits, clinical and psychosocial characteristics.
Psychooncology
; 31(5): 770-778, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34894364
11.
Strategies to successfully prevent COVID-19 outbreak in vulnerable uro-oncology patient population.
Infection
; 50(5): 1131-1137, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35201605
12.
Nintedanib plus mFOLFOX6 as second-line treatment of metastatic, chemorefractory colorectal cancer: The randomised, placebo-controlled, phase II TRICC-C study (AIO-KRK-0111).
Int J Cancer
; 148(6): 1428-1437, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32930387
13.
Mutational profiles of metastatic colorectal cancer treated with FOLFIRI plus cetuximab or bevacizumab before and after secondary resection (AIO KRK 0306; FIRE-3).
Int J Cancer
; 149(11): 1935-1943, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34310714
14.
Patients with colorectal cancer and brain metastasis: The relevance of extracranial metastatic patterns predicting time intervals to first occurrence of intracranial metastasis and survival.
Int J Cancer
; 148(8): 1919-1927, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33113215
15.
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial.
Br J Cancer
; 124(3): 587-594, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33154570
16.
Partition: a surjective mapping approach for dimensionality reduction.
Bioinformatics
; 36(3): 676-681, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31504178
17.
The relevance of CT-based geometric and radiomics analysis of whole liver tumor burden to predict survival of patients with metastatic colorectal cancer.
Eur Radiol
; 31(2): 834-846, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32851450
18.
Information, communication, and cancer patients' trust in the physician: what challenges do we have to face in an era of precision cancer medicine?
Support Care Cancer
; 29(4): 2171-2178, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32885314
19.
NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU.
Arch Gynecol Obstet
; 303(5): 1331-1345, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33277683
20.
Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer - translational results from the AIO-PK0104 Phase 3 study.
Br J Cancer
; 123(9): 1370-1376, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32830200